Monograph Modernization Initiative Looks To Close OTC Quality Loopholes
This article was originally published in The Pink Sheet Daily
Executive Summary
OTCs on the market through FDA's ingredient monograph system are something of a black box to regulators in terms of quality specs, CDER's Furness says.